source
- Novartis CEO says Trump’s drug pricing plan creates a very difficult situation for makers and patientsNovartis chief executive Vas Narasimhan warned that the United States drug‑pricing policy under President Trump presents a "very difficult situation" for both drugmakers and patients. He said the…
- AIDS advocacy group sues Trump administration over hidden Gilead HIV-prevention settlementThe AIDS advocacy group PrEP4All filed a lawsuit against the Trump administration, alleging it failed to disclose a research and development agreement with Gilead Sciences. The agreement was part…